vs
太平洋生物科学（ASMB）与Ready Capital Corp（RC）财务数据对比。点击上方公司名可切换其他公司
Ready Capital Corp的季度营收约是太平洋生物科学的1.2倍（$13.1M vs $10.8M），太平洋生物科学净利率更高（-85.2% vs -1772.7%，领先1687.5%），太平洋生物科学同比增速更快（57.6% vs -73.8%）
该公司是一家成立于2004年的美国生物科技企业，主要研发生产基因测序相关设备，同时也开展新型实时生物观测技术相关业务。目前拥有两大核心测序平台，分别是基于零模波导特性的单分子实时测序平台，以及结合天然核苷酸无痕连接技术的结合测序平台。
Ready Capital Corp是一家总部位于美国的商业地产金融企业，提供多户住宅贷款、小型商业地产抵押贷款、建筑融资及抵押贷款服务等定制化解决方案，核心客户覆盖美国各地的房地产投资者、小型企业运营者及地产开发商。
ASMB vs RC — 直观对比
营收规模更大
RC
是对方的1.2倍
$10.8M
营收增速更快
ASMB
高出131.4%
-73.8%
净利率更高
ASMB
高出1687.5%
-1772.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $10.8M | $13.1M |
| 净利润 | $-9.2M | $-232.6M |
| 毛利率 | — | — |
| 营业利润率 | -100.9% | -2013.3% |
| 净利率 | -85.2% | -1772.7% |
| 营收同比 | 57.6% | -73.8% |
| 净利润同比 | 4.3% | 26.1% |
| 每股收益（稀释后） | $-0.72 | $-1.43 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASMBRC
| Q4 25 | — | $13.1M | ||
| Q3 25 | $10.8M | $85.4M | ||
| Q2 25 | $9.6M | $16.9M | ||
| Q1 25 | $9.4M | $40.2M | ||
| Q4 24 | $7.4M | $50.1M | ||
| Q3 24 | $6.8M | $107.2M | ||
| Q2 24 | $8.5M | $51.0M | ||
| Q1 24 | $5.8M | $48.5M |
净利润ASMBRC
| Q4 25 | — | $-232.6M | ||
| Q3 25 | $-9.2M | $-16.7M | ||
| Q2 25 | $-10.2M | $-53.7M | ||
| Q1 25 | $-8.8M | $82.0M | ||
| Q4 24 | — | $-314.8M | ||
| Q3 24 | $-9.6M | $-7.3M | ||
| Q2 24 | $-11.2M | $-34.2M | ||
| Q1 24 | $-9.1M | $-74.2M |
营业利润率ASMBRC
| Q4 25 | — | -2013.3% | ||
| Q3 25 | -100.9% | -31.5% | ||
| Q2 25 | -115.2% | -524.9% | ||
| Q1 25 | -105.5% | — | ||
| Q4 24 | — | -629.0% | ||
| Q3 24 | -160.1% | -14.8% | ||
| Q2 24 | -143.0% | -157.0% | ||
| Q1 24 | -185.5% | -217.9% |
净利率ASMBRC
| Q4 25 | — | -1772.7% | ||
| Q3 25 | -85.2% | -19.6% | ||
| Q2 25 | -105.9% | -317.7% | ||
| Q1 25 | -93.6% | 203.7% | ||
| Q4 24 | — | -628.8% | ||
| Q3 24 | -140.4% | -6.8% | ||
| Q2 24 | -130.7% | -67.1% | ||
| Q1 24 | -156.9% | -152.8% |
每股收益（稀释后）ASMBRC
| Q4 25 | — | $-1.43 | ||
| Q3 25 | $-0.72 | $-0.13 | ||
| Q2 25 | $-1.33 | $-0.34 | ||
| Q1 25 | $-1.17 | $0.46 | ||
| Q4 24 | — | $-1.89 | ||
| Q3 24 | $-1.51 | $-0.07 | ||
| Q2 24 | $-1.98 | $-0.23 | ||
| Q1 24 | $-1.66 | $-0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.5M | $207.8M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $182.7M | $1.5B |
| 总资产 | $240.0M | $7.8B |
| 负债/权益比越低杠杆越低 | — | 0.89× |
8季度趋势，按日历期对齐
现金及短期投资ASMBRC
| Q4 25 | — | $207.8M | ||
| Q3 25 | $22.5M | $147.5M | ||
| Q2 25 | $24.0M | $162.9M | ||
| Q1 25 | $23.4M | $205.9M | ||
| Q4 24 | $38.3M | $143.8M | ||
| Q3 24 | $28.5M | $181.3M | ||
| Q2 24 | $19.2M | $226.3M | ||
| Q1 24 | $18.7M | $166.0M |
总债务ASMBRC
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.1B |
股东权益ASMBRC
| Q4 25 | — | $1.5B | ||
| Q3 25 | $182.7M | $1.8B | ||
| Q2 25 | $18.1M | $1.8B | ||
| Q1 25 | $27.1M | $1.9B | ||
| Q4 24 | $33.4M | $1.8B | ||
| Q3 24 | $26.0M | $2.2B | ||
| Q2 24 | $34.7M | $2.3B | ||
| Q1 24 | $32.6M | $2.4B |
总资产ASMBRC
| Q4 25 | — | $7.8B | ||
| Q3 25 | $240.0M | $8.3B | ||
| Q2 25 | $80.8M | $9.3B | ||
| Q1 25 | $99.0M | $10.0B | ||
| Q4 24 | $119.2M | $10.1B | ||
| Q3 24 | $100.3M | $11.3B | ||
| Q2 24 | $115.3M | $11.8B | ||
| Q1 24 | $119.9M | $12.0B |
负债/权益比ASMBRC
| Q4 25 | — | 0.89× | ||
| Q3 25 | — | 0.78× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.77× | ||
| Q4 24 | — | 0.73× | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-15.1M | $432.1M |
| 自由现金流经营现金流 - 资本支出 | $-15.2M | — |
| 自由现金流率自由现金流/营收 | -140.7% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ASMBRC
| Q4 25 | — | $432.1M | ||
| Q3 25 | $-15.1M | $434.7M | ||
| Q2 25 | $-16.8M | $-100.3M | ||
| Q1 25 | $-23.4M | $108.5M | ||
| Q4 24 | $-51.1M | $274.8M | ||
| Q3 24 | $-15.2M | $221.1M | ||
| Q2 24 | $-17.1M | $1.1M | ||
| Q1 24 | $-18.4M | $23.4M |
自由现金流ASMBRC
| Q4 25 | — | — | ||
| Q3 25 | $-15.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $-51.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-17.1M | — | ||
| Q1 24 | $-18.4M | — |
自由现金流率ASMBRC
| Q4 25 | — | — | ||
| Q3 25 | -140.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -695.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -200.6% | — | ||
| Q1 24 | -317.7% | — |
资本支出强度ASMBRC
| Q4 25 | — | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.4% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
现金转化率ASMBRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
